Evidence That Moves Medical Innovation Forward

Who We Are

TTi Health Research & Economics is a specialized research and consulting organization focused on helping MedTech and precision medicine companies demonstrate value in today’s evidence-driven healthcare environment.

We partner with innovators to design and execute clinical studies, real-world evidence, and health economic analyses that support payer decision-making, health system adoption, and long-term market access.

Our work goes beyond proving safety and performance — we focus on generating decision-relevant evidence that answers the questions payers, providers, and value committees actually ask.

Why TTi

What sets TTi apart is not just what we do — it’s how we do it.

  • Payer-first mindset: Evidence designed around coverage, reimbursement, and value assessment

  • Senior-level engagement: Direct access to experienced leaders throughout every engagement

  • MedTech-specific expertise: Strategies tailored to devices, diagnostics, and emerging technologies

  • Pragmatic execution: Studies designed to be feasible, defensible, and delivered on commercial timelines

Our Approach

Healthcare adoption depends on more than innovation. It depends on evidence that aligns with how coverage, reimbursement, and purchasing decisions are made.

TTi designs payer-informed evidence strategies that connect:

  • Clinical performance

  • Real-world outcomes

  • Economic value

We work across the product lifecycle — from late-stage clinical development through post-market growth — ensuring evidence strategies are feasible, defensible, and aligned with real-world decision frameworks.

Our team brings deep experience in medical devices, diagnostics, digital health, and emerging technologies, allowing us to tailor study designs and analyses to non-pharma pathways and evolving market expectations.

What We Do

We support clients through a comprehensive range of evidence generation and market access activities, including:

  • Clinical trial design and enhancement to support payer-relevant endpoints

  • Real-world and observational studies that extend clinical evidence into routine practice

  • Health economic and outcomes research (HEOR), including budget impact and cost-effectiveness analyses

  • Evidence strategy to support coverage applications, pricing, value dossiers, and health system review

  • Strategic consulting across market access, reimbursement, and commercialization planning

Our goal is simple: to help clients generate evidence that supports confident decisions and sustained adoption.